Hyperuricemia in leukemia and lymphoma.
D000086:Acetazolamide / Q000627:therapeutic use; D058186:Acute Kidney Injury / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D000493:Allopurinol / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001639:Bicarbonates / Q000627:therapeutic use; D003460:Crystallization; D004198:Disease Susceptibility; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007263:Infusions, Parenteral; D007938:Leukemia / Q000188:drug therapy* / Q000532:radiotherapy; D008223:Lymphoma / Q000188:drug therapy* / Q000532:radiotherapy; D008353:Mannitol / Q000627:therapeutic use; D010530:Peritoneal Dialysis; D011878:Radiotherapy / Q000009:adverse effects; D006435:Renal Dialysis; D014527:Uric Acid / Q000097:blood* / Q000378:metabolism
D000970:Antineoplastic Agents; D001639:Bicarbonates; D004234:Diuretics, Osmotic; D014527:Uric Acid; D008353:Mannitol; D000493:Allopurinol; D000086:Acetazolamide